Sanofi-Aventis Reshuffles Executive Committee; Widens Spek Role
French drugs company Sanofi-Aventis (SNY) Monday said it has
reshuffled its executive committe, adding the head of its vaccines
division Wayne Pisano and widening the scope of pharmaceutical
operations Executive Vice President Hanspeter Spek's duties to
cover global operations.
In a press release, Sanofi Chief Executive Chris Viehbacher said
he has promoted Marc Cluzel from senior vice president of research
and development to executive vice president of the division, citing
"the strategic importance of transforming" the division.
Under Viehbacher's lead, Sanofi has been paring its R&D
projects and focusing on developing partnerships with outside firms
to beef up products in the development pipeline.
The company's executive committee will meet twice a month,
Sanofi said in the statement.
Company Web site: www.sanofi-aventis.com
-By Mimosa Spencer, Dow Jones Newswires; +33 1 40 17 17 73;